ClariVest Asset Management’s Inspire Medical Systems INSP Stock Holding History

ClariVest Asset Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,244	Closed	-$994K	–	718
2023 Q1	$994K	Buy	4,244 +11	+0.3%	+$2.78K	0.04%	285
2022 Q4	$1.07M	Sell	4,233 -6	-0.1%	-$1.28K	0.05%	266
2022 Q3	$751K	Sell	4,239 -11	-0.3%	-$2.21K	0.04%	299
2022 Q2	$776K	Hold	4,250	–	–	0.03%	313
2022 Q1	$1.09M	Hold	4,250	–	–	0.04%	279
2021 Q4	$977K	Buy	+4,250	New	+$1.04M	0.03%	326

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ClariVest Asset Management's INSP Position: Q2 2023 in Review

ClariVest Asset Management sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 4,244 shares — an estimated $994K sold.

ClariVest Asset Management first reported a position in INSP in Q4 2021 and held it in 6 quarters. The position peaked at $1.09M in Q1 2022. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

ClariVest Asset Management reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
ClariVest Asset Management sold 4,244 Inspire Medical Systems shares in Q2 2023, an estimated $994K.
ClariVest Asset Management first reported a position in Inspire Medical Systems in Q4 2021 and held it in 6 quarters.
ClariVest Asset Management's Inspire Medical Systems position peaked at $1.09M in Q1 2022.
407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on ClariVest Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.